Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Allyl bromide M950093

 

CASRN: 106-95-6

Formula: C3-H5-Br

Synonyms/Common Names

  • AB
  • 3-Bromopropene
  • 3-Bromopropylene
  • 1-Propene, 3-bromo-
  • 2-Propenyl bromide

Known Uses

Starting material/chemical intermediate in organic synthesis & intermediate in the manufacture of polymers/resins, synthetic perfumes, pharmaceuticals, agricultural chemicals, and other allyl compounds.

Chemical Properties

Toxicity Effects (HSDB)

Short-Term Toxicity

  • 2 weeks (Topical Application)  (C96003B)  Completed 
    • Mice: FVB/N
    • Dose: 0, 7.5, 15, 30, 60 OR 120 MG/KG; 5/SEX/DOSE; 5X/WEEK.
  • 2 weeks (Gavage)  (C96003)  Completed 
    • Mice: C57BL/6
    • Dose: 0, 7.5, 15, 30, 60, OR 120 MG/KG; 5/SEX/DOSE; 5X/WEEK.
  • 40 weeks (Gavage)  (C96003C)  Completed 
    • GMM-07 (NIH Number: 08-4424)  (Peer Review Approval 08/28/2006A )
      Toxicology Studies of Allyl Bromide (CASRN 106-95-6) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Studies of Allyl Bromide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal and Gavage Studies)
    • Mice: FVB/N; Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: TG.AC: 0, 0.5, 1, 2, 4, OR 8 MG/KG; 15/SEX/DOSE FVB/N: 0 OR 8 MG/KG; 15/SEX/DOSE.
  • 40 weeks (Gavage)  (C96003)  Completed 
    • GMM-07 (NIH Number: 08-4424)  (Peer Review Approval 08/28/2006A )
      Toxicology Studies of Allyl Bromide (CASRN 106-95-6) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Studies of Allyl Bromide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal and Gavage Studies)
    • Mice: C57BL/6; Mice: P53 +/- (C57BL/6)
    • Dose: P53: 0, 0.5, 1, 2, 4 OR 8 MG/KG; 15/SEX/DOSE C57BL/6: 0 OR 8 MG/KG; 15/SEX/DOSE.

Special Studies

  • Toxicokinetic Study (in-vitro)  (S0667)  Completed 
    • Rats: F344/N

Genetic Toxicology

  • Micronucleus  (A03068)  Completed 
    • Mice: Tg.AC
    • Male Negative 
    • Female Negative 
  • Micronucleus  (A27120)  Completed 
    • Mice: FVB/N
    • Male Negative 
    • Female Negative 
  • Micronucleus  (A43640)  Completed 
    • Mice: P53 +/- (C57BL/6)
    • Male Negative 
    • Female Negative 
  • Micronucleus  (A87628)  Completed 
    • Mice: C57BL/6
    • Male Negative 
    • Female Negative 
  • Salmonella  (A92510)  Completed 
    •  Positive